1-methoxyindole-3-carboxamide | 91913-78-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吲哚及其衍生物
• 英文名称: 1-methoxyindole-3-carboxamide
• CAS: 91913-78-9
• 化学式: C₁₀H₁₀N₂O₂
• 分子量: 190.202
• InChiKey: XPWORMGBOSHIHN-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.3
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  57.2
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  1-羟基吲哚 在 甲醇 、 sodium hydroxide 、 双氧水 、 sodium 、 三乙胺 作用下， 以 乙醚 、 乙醇 为溶剂， 反应 30.0h， 生成 1-methoxyindole-3-carboxamide
  参考文献：
  名称：

  Acheson, R. Morrin; Aldridge, Graham N.; Choi, Michael C. K., Journal of Chemical Research, Miniprint, 1984, # 4, p. 1301 - 1319

  摘要：

  DOI：

文献信息

• Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer
  申请人：EPIZYME, INC.

  公开号：US10266526B2

  公开（公告）日：2019-04-23

  The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.

  本公开提供了具有式（I）的羧酰胺类和磺酰胺类化合物：及其药学上可接受的盐和溶剂，其中A、Y、B、X和Z的定义如说明书所述。本公开还涉及使用式（I）化合物治疗对 SMYD 蛋白如 SMYD3 或 SMYD2 的阻断有反应的紊乱。本公开的化合物尤其适用于治疗癌症。
• ACHESON, R. M.;ALDRIDGE, G. N.;CHOI, M. C. K.;NWANKWO, J. O.;RUSCOE, M. A+, J. CHEM. RES. MICROFICHE, 1984, N 4, 101
  作者：ACHESON, R. M.、ALDRIDGE, G. N.、CHOI, M. C. K.、NWANKWO, J. O.、RUSCOE, M. A+

  DOI：——

  日期：——
• Methoxybrassenins A and B, sulphur-containing stress metabolites from Brassica oleracea var. Capitata
  作者：Kenji Monde、Keiji Sasaki、Akira Shirata、Mitsuo Takasugi

  DOI：10.1016/0031-9422(91)83435-n

  日期：1991.1

  Two methoxybrassinin-related stress metabolites, named methoxybrassenins A and B, were isolated from Brassica oleracea var. capitata inoculated with Pseudomonas cichorii. Their structures have been elucidated by spectroscopic and chemical methods. The unusual NMR spectrum of methoxybrassenin B is also discussed in connection with its structure.
• SMYD Inhibitors
  申请人：EPIZYME, INC.

  公开号：US20170355695A1

  公开（公告）日：2017-12-14

  The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmaceutically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.
• SMYD INHIBITORS
  申请人：EPIZYME, INC.

  公开号：US20190322660A1

  公开（公告）日：2019-10-24

  The present disclosure provides carboxamides and sulfonamides having Formula (I): and the pharmacentically acceptable salts and solvates thereof, wherein A, Y, B, X, and Z are defined as set forth in the specification. The present disclosure is also directed to the use of compounds of Formula (I) to treat a disorder responsive to the blockade of SMYD proteins such as SMYD3 or SMYD2. Compounds of the present disclosure are especially useful for treating cancer.